Vertebrobasilar thrombolysis with intravenous tirofiban: case report.

Authors

David S Liebeskind
John R Pollard
Eric D Schwartz
Brett L Cucchiara
Michael L McGarvey
Robert W Hurst

Publication/Presentation Date

4-1-2002

Abstract

The use of thrombolytic agents in the setting of established cerebral infarction is limited by concerns for hemorrhagic transformation. Novel thrombolytic approaches, which have received minimal consideration, may be associated with lower risks of hemorrhage. We illustrate vertebrobasilar thrombolysis with intravenous tirofiban, a selective platelet glycoprotein IIb/IIIa receptor antagonist, and discuss the potential thrombolytic properties of this class of antithrombotics.

Volume

13

Issue

2

First Page

81

Last Page

84

ISSN

0929-5305

Published In/Presented At

Liebeskind, D. S., Pollard, J. R., Schwartz, E. D., Cucchiara, B. L., McGarvey, M. L., & Hurst, R. W. (2002). Vertebrobasilar thrombolysis with intravenous tirofiban: case report. Journal of thrombosis and thrombolysis, 13(2), 81–84. https://doi.org/10.1023/a:1016242713327

Disciplines

Diagnosis | Medicine and Health Sciences | Other Analytical, Diagnostic and Therapeutic Techniques and Equipment | Radiology

PubMedID

12101384

Department(s)

Department of Radiology and Diagnostic Medical Imaging

Document Type

Article